SCHEMBL21029906

SCHEMBL21029906

CCNc1nc2c(ncn2[C@H]2CCCO2)c(=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
YTHDC1 Q96MU7 1/20 0.47
CYP2C19 P33261 1/20 0.45
KMT2A Q03164 4/20 0.45
MEN1 O00255 3/20 0.45
ALDH1A1 P00352 3/20 0.45
TP53 P04637 1/20 0.45
CYP2C9 P11712 1/20 0.45
NFKB1 P19838 1/20 0.45
MAPK1 P28482 1/20 0.45
HSD17B10 Q99714 1/20 0.45
APEX1 P27695 1/20 0.45
PI4KA P42356 1/20 0.45
BLM P54132 1/20 0.45
ADCY1 Q08828 1/20 0.45
PI4K2B Q8TCG2 1/20 0.45
PI4K2A Q9BTU6 1/20 0.45
PI4KB Q9UBF8 1/20 0.45
POLA1 P09884 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21082615 0.90 POLA1 (0.46) YTHDC1CYP2C19KMT2AMEN1ALDH1A1
SCHEMBL29665047 0.81 KDM4E (0.56) YTHDC1CYP2C19KMT2AMEN1ALDH1A1
SCHEMBL6283863 0.76 POLA1 (0.69) TP53POLA1SMN1; SMN2KDM4ELMNA
SCHEMBL15720909 0.76 POLA1 (0.69) TP53POLA1SMN1; SMN2KDM4ELMNA
SCHEMBL8540848 0.76 POLA1 (0.69) TP53POLA1SMN1; SMN2KDM4ELMNA
SCHEMBL23648123 0.76 POLA1 (0.69) TP53POLA1SMN1; SMN2KDM4ELMNA
SCHEMBL1713327 0.76 YTHDC1 (0.57) YTHDC1CYP2C19KMT2AMEN1ALDH1A1
SCHEMBL20240172 0.72 HPGD (0.69) TP53LMNA
SCHEMBL20230464 0.71 POLA1 (0.46) KMT2AMEN1ALDH1A1POLA1KDM4E
SCHEMBL21029537 0.70 MEN1 (0.60) YTHDC1CYP2C19KMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2971033-B1 MANUFACTURING METHODS FOR PRODUCTION OF RNA TRANSCRIPTS MODERNA THERAPEUTICS INC (US) 2019-05-29 EP disclosed